explore -WSS

explore

author：focus 2025-10-02 23:47:13 - browse：3488

Novo Nordisk Denmark — LISELOTTE SABROE/AFP/Getty Images

A pill being developed by Danish drugmaker Novo Nordisk may lead to greater weight loss than the obesity therapy Wegovy, the company reported Thursday, citing early data.

In a Phase 1 trial, participants experienced an average of 13.1% weight loss after 12 weeks of taking the experimental oral medicine amycretin, according to data presented at an investor meeting. In comparison, in an earlier Phase 3 trial of the injectable drug Wegovy, people taking Wegovy lost about 6% of their body weight over the same time period.

Novo Nordisk has been on a mission to capitalize on its success with Wegovy, which brought in $4.5 billion in sales last year. (The drug is also sold as a diabetes treatment under the name Ozempic. That version of the drug brought in another $14 billion in sales).

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Making AI in medicine accessible to smaller, and rural hospitals

focus

WSS

Malaysia cuts short music fest after British band slams anti

Study: Adult vaccinations pay for themselves in societal benefits

Charges dismissed against white woman who spat on Black woman during protests in Connecticut

Shionogi licenses Pompe disease therapy from Maze Therapeutics

Severe heat forecast: Where scorching temperatures will persist over the next week

It shouldn't be easy to buy synthetic DNA to recreate a deadly virus

explore

explore

focus

As demand for Covid shots wanes, Moderna seeks its next success

Alcohol isn't healthy after all. Will new dietary guidelines reflect that?

Duchenne breakthrough therapy leaves behind pioneering families

Shionogi licenses Pompe disease therapy from Maze Therapeutics

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

H5N1 bird flu: what we're starting to learn about infection in cows

Jerome Adams on the need for new antivirals for Covid

Dairy farmers resist CDC push for PPE against bird flu virus

Medical records are filled with copy

Elevance, private equity launch primary care company

focus

What nurses really want: sufficient staffing for patient care

Study: People of West African ancestry at greater risk of cardiac amyloidosis

First recipient of genetically engineered pig kidney has died

What Henrietta Lacks's story taught me about my role as a doctor

FAMU bans football players from facility after release of rap video shot in team's locker room

Where does female orgasm come from? Scientists think they know

hotspot

hotspot

focus

explore